Blockchain Technologies in Healthcare

    Published: November 22, 2019 | Price: $2,000.00 – $4,000.00

    Blockchain is essentially a tool that has the potential to keep secure data in a distributed ledger with the capability to be shared across networks. The concept behind blockchain is that it has three components: a widely distributed network a shared ledger with validated access identities digital transactions Blockchain technology is emerging in many other industries but it has some unique challenges in healthcare. Blockchain Technologies in Healthcare discusses some of the major application areas for blockchain technology in healthcare:...
    Indonesia IVD Market Analysis

    Published: July 19, 2017 | Price: $3,360.00 – $6,720.00

    Indonesia IVD Market Analysis Indonesia IVD Market Analysis provides market segmentation, discusses healthcare and regulatory trends, and examines in vitro diagnostics (IVD) manufacturers participating in Indonesia's marketplace. The following revenue information for 2017-2022 Indonesian IVD market segments is provided: Rapid Tests for Infectious Diseases by Category (HIV; STDs; Hepatitis [HBV, HCV, etc.]; Other [includes Dengue, Malaria, Typhoid, RSV, Filariasis, etc.]; Rapid Tests-Infectious Diseases, Total) Microbiology (Rapid Tests-Infectious Diseases; Lab-based Immunoassays - Infectious Diseases; Molecular Diagnostics - Microbiology; Other [includes supplies,...
    Stem Cell Therapeutics Markets

    Published: February 1, 2009 | Price: $995.00 – $5,000.00

    Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. With their ability to differentiate and become an ongoing source of cells...
    Stem Cells – Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

    Published: March 1, 2008 | Price: $995.00 – $7,800.00

    With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug...
    Healthcare-Associated Infection Testing (HAI) – The “Prevention Effect” on Diagnostic Markets

    Published: September 7, 2017 | Price: $2,400.00 – $4,800.00

    This report takes a look at both prevention procedures such as sterilization and surface area disinfection and testing such as molecular tests and immunoassays.  Infection control in healthcare facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of healthcare is known as a nosocomial, or hospital acquired, infection. What...
    Vaccines 2020: World Market Analysis, Players, Trends

    Published: November 4, 2020 | Price: $4,000.00 – $8,000.00

    Vaccine Market Tops 37 Billion, Says Kalorama Information Report In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information's report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025. THE MOST CURRENT VACCINE MARKET INFORMATION  The vaccine market is a growth market for the experienced competitors participating in it.Seven billion dollars in new sales have occurred in the past...
    Liquid Chromatography Markets (LC, HPLC and UHPLC)

    Published: March 1, 2009 | Price: $1,995.00 – $3,990.00

    The liquid chromatography (LC) market has been relatively mature for quite a while, with a slow evolution of products and applications over the last few decades. High performance liquid chromatography (HPLC) has used essentially the same types of components since the 1980s. However, the market has seen an extraordinary amount of technological change in the last few years as companies have continued to introduce new systems performing fast LC and ultra HPLC (UHPLC). This report, Liquid Chromatography Markets,, represents Kalorama's...
    Clinical Laboratory Services Market: Forecasts to 2020

    Published: October 1, 2015 | Price: $1,995.00 – $3,995.00

    Clinical Laboratory Services Market This report, Clinical Laboratory Services Market, provides an in-depth market overview, a total market analysis, analysis by laboratory type, and by routine and specialty testing and a review of the latest trends driving growth. Revenues and forecasts, segment breakouts and market share presented are for the U.S. market, but international clinical lab service markets are estimated and forecasted in this report. Laboratory services are a key component of the healthcare system and an important part of...
    Emerging Infectious Disease Diagnostics: Markets and Trends

    Published: May 27, 2020 | Price: $3,000.00 – $6,000.00

    In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away.  Where could the next pandemic or epidemic come from?   There are a number of diseases currently tracking as moving from the developed world to the developing world? Kalorama has addressed emerging infectious disease since our first study nine...
    European IVD Market Summary

    Published: October 25, 2018 | Price: $1,500.00 – $3,000.00

    This brief report contains Kalorama Information's estimates of European in vitro diagnostics markets including current (2018) country level estimates and forecasts. Content for this report is based on information in The Worldwide Market for In Vitro Diagnostic Tests, 11th Edition, with additional forecasting information.
    Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests)

    Published: August 15, 2014 | Price: $3,995.00 – $7,990.00

    Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests) Physician office laboratories are a diverse but significant market for IVD products. The range of POLs is vast: Individual physicians may peform in-office pregnancy and glucose tests, run automated CBCs and chemistry panels or perform moderate complexity infectious disease tests using plate immunoassays and molecular assays. This report, Physician Office Laboratory Markets is...
    SNP Genotyping and Analysis Markets and the Future of SNPs in Personalized Medicine

    Published: February 1, 2010 | Price: $1,995.00 – $4,000.00

    Because SNPs are the most common type of genetic variation between human beings, these specific single base pair mutations can be ideal for the task of hunting for correlations between genotype and behavior or quality exhibited by a living organism. For this reason, SNP analysis represents one of many possible pathways to personalzied medicine. The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and pharmacogenomics are the most promising applications, and Kalorama has followed...
    Wound Care, 3rd Edition, Vol. II: Burns

    Published: September 1, 2007 | Price: $2,995.00 – $5,990.00

    2008 has seen no decrease in attention on wound care products. The aging of the population and a constant demand for products that speed healing and improve outcomes drives the wound care industry. For market watchers, this makes for a dynamic market that has changed in recent years with biological developments. Kalorama Information's analyst Mary Ann Crandall has reviewed the Wound Care Industry in several editions of wound care market reports and has participated in industry panels. Kalorama Information's three-volume...
    Drug Delivery Markets: Oral Delivery

    Published: July 1, 2000 | Price: $995.00 – $5,990.00

    Since our last edition of this report in 2007, the oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderly population that requires products with a level of ease-of-use and cost benefit, it’s no surprise that the oral drug delivery market is a...
    Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003

    Published: March 1, 2004 | Price: $795.00 – $1,590.00

    The hard-fought battle over Medicare's prescription drug benefit is over, but the long-term effects of the new law are still unclear. Exactly who will benefit and by how much? Is it a victory for big pharma? Initial reactions are not always correct, and this examination into the true implications for pharmaceutical markets looks at all the facts. This market briefing from Kalorama describes and assesses the provisions of the "Medicare Prescription Drug, Improvement and Modernization Act of 2003" and predicts...